Evidence map›Paper›PMID 34692949›Full record

ArticleData in brief2021

Dataset on insightful bio-evaluation of 2-(quinoline-4-yloxy)acetamide analogues as potential anti-

Abel Kolawole Oyebamiji, Olubunmi Modupe Josiah, Sunday Adewale Akintelu, Moriam Dasola Adeoye, Babatunde Olasupo Sabitu, Dayo Felix Latona, Akintomiwa O Esan, Emmanuel Ayodele Soetan, Banjo Semire

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Data in brief, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abel Kolawole OyebamijiDepartment of Pure and Applied Chemistry, Computational Chemistry Research Laboratory, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.
Olubunmi Modupe JosiahDepartment of Basic Sciences, Adeleke University, Ede, Osun State, Nigeria.
Sunday Adewale AkinteluSchool of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, China.
Moriam Dasola AdeoyeDepartment of Chemical Sciences, Fountain University, Osogbo, Nigeria.
Babatunde Olasupo SabituNational Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria.
Dayo Felix LatonaDepartment of Pure and Applied Chemistry, Osun State University, Osogbo, Nigeria.
Akintomiwa O EsanDepartment of Pure and Applied Chemistry, Computational Chemistry Research Laboratory, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.
Emmanuel Ayodele SoetanDepartment of Pharmacology, College of Medicine, Bowen University, Iwo, Osun State, Nigeria.
Banjo SemireDepartment of Pure and Applied Chemistry, Computational Chemistry Research Laboratory, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous havoc wrecked by tuberculosis among humans worldwide remains colossal. In this work, twenty-one (21) 2-(quinoline-4-yloxy)acetamide analogues were observed against

Indexed as

2-(quinoline-4-yloxy)acetamideADMETDFTDockingQSARTuberculosis

Identifiers

PMID34692949
PMCPMC8511800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.